Cooper Companies, Inc. (The) (NYSE:COO) Position Lowered by Nuveen Asset Management LLC

Nuveen Asset Management LLC decreased its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 89.6% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,932 shares of the medical device company’s stock after selling 16,624 shares during the period. Nuveen Asset Management LLC’s holdings in Cooper Companies, Inc. (The) were worth $386,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of COO. Genesee Valley Trust Co. boosted its position in Cooper Companies, Inc. (The) by 1.1% in the first quarter. Genesee Valley Trust Co. now owns 1,957 shares of the medical device company’s stock worth $391,000 after buying an additional 21 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares during the last quarter. Glen Harbor Capital Management LLC raised its stake in shares of Cooper Companies, Inc. (The) by 2.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,344 shares of the medical device company’s stock worth $269,000 after buying an additional 32 shares during the last quarter. First Bank & Trust raised its stake in shares of Cooper Companies, Inc. (The) by 3.6% in the first quarter. First Bank & Trust now owns 1,056 shares of the medical device company’s stock worth $211,000 after buying an additional 37 shares during the last quarter. Finally, Argent Trust Co raised its stake in shares of Cooper Companies, Inc. (The) by 1.0% in the first quarter. Argent Trust Co now owns 4,096 shares of the medical device company’s stock worth $819,000 after buying an additional 39 shares during the last quarter. 98.06% of the stock is currently owned by institutional investors.

Shares of Cooper Companies, Inc. (COO) opened at 245.05 on Friday. The stock’s 50 day moving average is $245.29 and its 200-day moving average is $217.13. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The firm has a market cap of $11.97 billion, a P/E ratio of 36.74 and a beta of 0.61.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million during the quarter, compared to analysts’ expectations of $520.71 million. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.05 earnings per share. Analysts anticipate that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.

The firm also recently announced a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were paid a $0.03 dividend. This represents a yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is presently 0.90%.

ILLEGAL ACTIVITY NOTICE: “Cooper Companies, Inc. (The) (NYSE:COO) Position Lowered by Nuveen Asset Management LLC” was first published by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/cooper-companies-inc-the-nysecoo-stake-cut-by-nuveen-asset-management-llc-updated-updated.html.

A number of analysts have weighed in on the company. Piper Jaffray Companies upped their target price on Cooper Companies, Inc. (The) to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. BidaskClub lowered Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Zacks Investment Research lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Thursday, June 22nd. Guggenheim started coverage on Cooper Companies, Inc. (The) in a research report on Thursday, June 29th. They issued a “neutral” rating on the stock. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $255.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $242.00.

In other news, CEO Paul L. Remmell sold 9,294 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $248.46, for a total value of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares of the company’s stock, valued at $1,536,973.56. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Randal Golden sold 1,621 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total transaction of $394,956.65. Following the completion of the transaction, the vice president now directly owns 1,731 shares in the company, valued at approximately $421,758.15. The disclosure for this sale can be found here. Insiders sold 67,331 shares of company stock valued at $16,400,454 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply